Protein C News and Research

RSS

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Researchers have presented the results of phase 1 and phase 2 clinical trials of a SARS-CoV-2 recombinant spike protein vaccine (Abdala).

6 Dec 2021

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

This work has emphasized the clinical and translational potential of paper-based biosensors.

6 Dec 2021

SARS-CoV-2 immune memory in mRNA vaccine recipients

Researchers measured SARS-CoV-2–specific antibody, memory B cell, and memory T cell responses in a group of healthy subjects who generated primary immune responses to two doses of mRNA vaccine compared to a group of SARS-CoV-2–recovered vaccines.

6 Dec 2021

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

A new study argues that that rapid genomic sequence surveillance is absolutely crucial and Tajima D tests should be included to predict future COVID-19 outbreaks.

6 Dec 2021

Announcing the Winners of The Scientist’s Top 10 Innovations of 2021

Each year The Scientist seeks to highlight the latest and greatest tools, technologies, and techniques to hit the life science landscape.

From Resolve Biosciences 6 Dec 2021

The link between cytokine storms and cardiovascular problems in COVID-19 patients

New findings may help doctors choose effective COVID-19 treatment regimens for patients with heart complications.

6 Dec 2021

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

Sino Biological, Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus

From Sino Biological Inc. 6 Dec 2021

Mutations in a crucial gene responsible for chemotherapy failure in some blood cancer patients

Mutations in a crucial gene are the key reason that chemotherapy fails in some patients with blood cancer, a study by Nanyang Technological University, Singapore (NTU Singapore) and Singapore General Hospital (SGH) has found.

6 Dec 2021

Equipment-free handheld microfluidic injection provides visible readout of SARS-CoV-2 detection

In this paper, a group of researchers from Harvard Medical School, McGill University, and Tianjin University describes an on-chip diagnostic technology for the direct detection of SARS-CoV-2 N protein in nasal samples that combines the advantages of hydrodynamic microfluidic filtration and sandwich immunoassay.

5 Dec 2021

SARS-CoV-2 ORF10 degrades mitochondrial antiviral signaling protein to suppress immune response

A novel mechanism by which SARS-CoV-2 inhibits the innate immune response; that is, ORF10 induces mitophagy-mediated MAVS degradation by binding to NIX.

5 Dec 2021

Scientists identify molecular features of antibody responses to SARS-CoV-2 spike

New study identifies diverse molecular features of public antibody responses to SARS-CoV-2 spike protein.

5 Dec 2021

Preclinical data shows enhanced T-cell responses & neutralization of SARS-CoV-2 variants with ImmunityBio heterologous vaccination

A new study supports the hypothesis that heterologous vaccination can provide an increased immune response against virus infection, supporting several other studies that have indicated similar events.

5 Dec 2021

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

A new case study on the report of multisystem inflammatory syndrome (MISC) in a 22-year-old woman in South Korea after vaccination.

5 Dec 2021

The emergence and evolution of SARS-CoV-2 and its VOCs

A review article discusses the evolution of SARS-CoV-2 and the emergence of variants of concern.

5 Dec 2021

New test can quickly and easily assess antibody effectiveness against COVID-19 variants

Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.

4 Dec 2021

Targeting the brain should be the focus of ALS therapy, not just spinal cord

The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists have discovered.

4 Dec 2021

Lack of protein in the diet of women over 65 linked to sarcopenia and sarcopenic obesity

Different institutions, including the University of Valencia (UV), have studied the relationship between sarcopenia (loss of muscle mass in older people) and obesity derived from this condition with a lack of protein in the diet of women over 65 years of age.

4 Dec 2021

Protein C News and Research

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

SARS-CoV-2 immune memory in mRNA vaccine recipients

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

Announcing the Winners of The Scientist’s Top 10 Innovations of 2021

The link between cytokine storms and cardiovascular problems in COVID-19 patients

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

Mutations in a crucial gene responsible for chemotherapy failure in some blood cancer patients

Equipment-free handheld microfluidic injection provides visible readout of SARS-CoV-2 detection

SARS-CoV-2 ORF10 degrades mitochondrial antiviral signaling protein to suppress immune response

Scientists identify molecular features of antibody responses to SARS-CoV-2 spike

Preclinical data shows enhanced T-cell responses & neutralization of SARS-CoV-2 variants with ImmunityBio heterologous vaccination

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

The emergence and evolution of SARS-CoV-2 and its VOCs

New test can quickly and easily assess antibody effectiveness against COVID-19 variants

Targeting the brain should be the focus of ALS therapy, not just spinal cord

Lack of protein in the diet of women over 65 linked to sarcopenia and sarcopenic obesity

'Combination' adjuvant may boost the protective power of vaccines

Telomeric DNA damage response may increase susceptibility of elderly people to COVID-19

New nanoparticle adjuvant could help make vaccines more powerful

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News